Trulieve Cannabis (TSE:TRU) Upgraded at Cormark

Cormark upgraded shares of Trulieve Cannabis (TSE:TRU) from a hold rating to a moderate buy rating in a research note published on Monday morning,Zacks.com reports.

Other equities research analysts also recently issued reports about the stock. Atb Cap Markets raised shares of Trulieve Cannabis from a “hold” rating to a “strong-buy” rating in a research report on Monday, December 9th. Craig Hallum upgraded shares of Trulieve Cannabis to a “strong-buy” rating in a report on Wednesday, February 26th.

Trulieve Cannabis Price Performance

Insider Activity at Trulieve Cannabis

In other news, Senior Officer Wes Getman purchased 9,500 shares of the business’s stock in a transaction dated Friday, December 13th. The stock was bought at an average price of C$7.02 per share, for a total transaction of C$66,702.35.

About Trulieve Cannabis

TransUnion provides risk and information solutions. The company operates in three segments: U.S. Markets, International, and Consumer Interactive. The U.S. Markets segment provides consumer reports, actionable insights, and analytics to businesses. These businesses use its services to acquire new customers; assess consumer ability to pay for services; identify cross-selling opportunities; measure and manage debt portfolio risk; collect debt; verify consumer identities; and mitigate fraud risk.